Patents by Inventor Jan Schwab

Jan Schwab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10201706
    Abstract: Methods for improving an inflammatory disorder in a subject are provided. Methods include positioning a therapy delivery device on a neural target site that contributes to immune activity of the subject. The therapy delivery device is activated to deliver a therapy signal to the neural target site to improve the subject's inflammatory disorder.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: February 12, 2019
    Assignee: Ohio State Innovation Foundation
    Inventors: Jan Schwab, Phillip Popovich, Ali R. Rezai
  • Publication number: 20170120046
    Abstract: Methods for improving an inflammatory disorder in a subject are provided. Methods include positioning a therapy delivery device on a neural target site that contributes to immune activity of the subject. The therapy delivery device is activated to deliver a therapy signal to the neural target site to improve the subject's inflammatory disorder.
    Type: Application
    Filed: December 19, 2016
    Publication date: May 4, 2017
    Inventors: Jan Schwab, Phillip Popovich, Ali R. Rezai
  • Publication number: 20170100604
    Abstract: Methods for improving metabolic syndrome in a subject are provided. Methods include positioning a therapy delivery device on a neural target site that contributes to immune activity of the subject. The therapy delivery device is activated to deliver a therapy signal to the neural target site to improve the subject's metabolic syndrome.
    Type: Application
    Filed: December 19, 2016
    Publication date: April 13, 2017
    Inventors: Jan Schwab, Phillip Popovich, Ali R. Rezai
  • Publication number: 20170100605
    Abstract: Methods for improving an immune disorder in a subject are provided. The immune disorder can be an autoimmune disorder, a hypersensitivity syndrome, or an immune deficiency syndrome. Methods include positioning a therapy delivery device on a neural target site that contributes to immune activity of the subject. The therapy delivery device is activated to deliver a therapy signal to the neural target site to improve the subject's immune disorder.
    Type: Application
    Filed: December 19, 2016
    Publication date: April 13, 2017
    Inventors: Jan Schwab, Phillip Popovich, Ali R. Rezai
  • Publication number: 20170100589
    Abstract: Methods for improving infection in a subject are provided. Methods include positioning a therapy delivery device on a neural target site that contributes to immune activity of the subject. The therapy delivery device is activated to deliver a therapy signal to the neural target site to improve the subject's infection.
    Type: Application
    Filed: December 19, 2016
    Publication date: April 13, 2017
    Inventors: Jan Schwab, Phillip Popovich, Ali R. Rezai
  • Publication number: 20170100588
    Abstract: Methods for improving cancer symptoms in a subject are provided. Methods include positioning a therapy delivery device on a neural target site that contributes to immune activity of the subject. The therapy delivery device is activated to deliver a therapy signal to the neural target site to improve the subject's cancer symptoms.
    Type: Application
    Filed: December 19, 2016
    Publication date: April 13, 2017
    Inventors: Jan Schwab, Phillip Popovich, Ali R. Rezai
  • Publication number: 20160331962
    Abstract: Methods for modulating immune function in a patient are provided. Methods include improving an immune response in a patient suffering from a condition resulting or caused by a deficient immune system. A step in such a method includes positioning a therapy delivery device on a neural target site of a maladaptive sympathetic reflex of the patient. An additional step includes activating the therapy delivery device to deliver a therapy signal to the neural target site to improve the patient's immune response.
    Type: Application
    Filed: May 16, 2016
    Publication date: November 17, 2016
    Inventors: Jan Schwab, Phillip Popovich, Ali R. Rezai
  • Publication number: 20040151739
    Abstract: The invention relates to the use of a composition, comprising a fusion protein and at least one transporter for the in-vivo inhibition of scar tissue formation, the in-vivo reduction of secondary damage and/or the in-vivo accumulation of macrophages. The fusion protein contains at least one binding domain for the transporter and at least one modulation domain for the covalent modification of small GTP-binding proteins. The transporter permits the uptake of the fusion protein in a target cell.
    Type: Application
    Filed: March 26, 2004
    Publication date: August 5, 2004
    Inventors: Philippe P. Monnier, Bernhard K. Mueller, Jan Schwab